EU/3/19/2181

About

On 25 July 2019, orphan designation EU/3/19/2181 was granted by the European Commission to Cebiotex S.L., Spain, for 7-ethyl-10-hydroxy-camptothecin for the treatment of soft tissue sarcoma.

Key facts

Active substance
7-ethyl-10-hydroxy-camptothecin
Disease / condition
Treatment of soft tissue sarcoma
Date of first decision
25/07/2019
Outcome
Positive
EU designation number
EU/3/19/2181

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

Cebiotex S.L.
Calle Baldiri Reixac Nº 4
08028 Barcelona
Spain
Tel: +34935285385
E-mail: info@cebiotex.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating